ETIDIOH - NEW: pandemic influenza

Showing posts with label pandemic influenza. Show all posts

Saturday, September 26, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, September 26 '26)

Arch Virol

LEE K, An SH, Heo GB, Lee YJ, et al
Correction: Genomic characterization of H6N1 avian influenza viruses from wild birds and domestic ducks in the republic of Korea and Mongolia (2022-2024).
Arch Virol. 2026;171:283.
PubMed

Biochem Soc Trans

CAWTHORNE W, Zhang Y, Val N, Nelson M, et al
Unmasking programmed cell death in rhinovirus-driven asthma pathology.
Biochem Soc Trans. 2026;54:1359-1373.
PubMed Abstract available

BMC Pediatr

SU L, Chen HS, Qiu WL, Zhong WM, et al
The rationality of drug treatment and clinical characteristics in children with SARS-CoV-2 infection: a retrospective analysis.
BMC Pediatr. 2026;26:894.
PubMed Abstract available

Epidemiol Infect

MITCHELL E, Zhu H, Fitzpatrick T, Majoe A, et al
Social disparities and the COVID-19, influenza, and RSV 'tripledemic' in Ontario, Canada: A population-based study.
Epidemiol Infect. 2026;154:e117.
PubMed Abstract available

Eur J Epidemiol

ANDREASSON J, Bennet L, Bjork J, Dietler D, et al
SARS-CoV-2 infection as a trigger of type 2 diabetes in adults: a population-based cohort study in Sweden using a double negative control design.
Eur J Epidemiol. 2026;41:959-967.
PubMed Abstract available

HELLE S, Tanskanen AO, Danielsbacka M
The decade of double-trouble: live birth and stillbirth sex ratio variation in Finland during the COVID-19 pandemic and Russia's attack on Ukraine.
Eur J Epidemiol. 2026;41:1019-1028.
PubMed Abstract available

J Infect Dis

SCHUMER C, Mann AJ, Fourati S, Lukas P, et al
Viral Dynamics of the Respiratory Syncytial Virus During Experimental Human Challenge: Implication for Transmission and Protection.
J Infect Dis. 2026;234:407-416.
PubMed Abstract available

ALKARKOUKLY S, Hambo S, Menk M, Spieth P, et al
Regulatory T-Cell Notch4 Expression Correlates With Mortality in Patients Hospitalized With COVID-19.
J Infect Dis. 2026;234:396-406.
PubMed Abstract available

ENGELMANN I, Pisoni A, Mille C, Ayadi M, et al
Age-Dependent Clinical and Molecular Rhinovirus Epidemiology, 2018-2023.
J Infect Dis. 2026;234:417-426.
PubMed Abstract available

MCCULLOCH DJ, Khawaja F, Tverdek FP, Ford ES, et al
First Report on Remdesivir Use for the Treatment of Respiratory Syncytial Virus in Five Allogeneic Hematopoietic Cell Transplant Recipients.
J Infect Dis. 2026;234:e552-e555.
PubMed Abstract available

MARCHAL A, Kerdiles T, Perrin A, Gervais A, et al
High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Patients With Blood Autoantibodies Neutralizing Type I Interferons.
J Infect Dis. 2026;234:e515-e521.
PubMed Abstract available

ROEN AO, Hedberg P, Pereira JPV, Zazzi M, et al
Increased In-Hospital Mortality in Immunocompromised Individuals Hospitalized With COVID-19 During the Global Pandemic: A Multinational Cohort Study in the EuCARE Project.
J Infect Dis. 2026;234:e496-e505.
PubMed Abstract available

FREYN AW, Budigi Y, Girard B, Santos G, et al
Cell-Mediated Immunity of mRNA-1283 Vaccine Encoding SARS-CoV-2 Spike Receptor-Binding and N-Terminal Domains in Preclinical and Clinical Studies.
J Infect Dis. 2026 Jun 4:jiag248. doi: 10.1093.
PubMed Abstract available

J Virol

ZHANG L, Chen N, Eichmann A, Nehlmeier I, et al
The conserved QTQTX motif in the SARS-CoV-2 spike protein is dispensable for cleavage and lung cell entry of the emerging variant BA.3.2.
J Virol. 2026 Aug 5:e0069126. doi: 10.1128/jvi.00691.
PubMed Abstract available

RIOS CARRASCO M, Guerreiro Cabana MF, Kovacs E, Ducarne Z, et al
Acquisition of specific human respiratory tract binding by 2.3.4.4b H5N1 hemagglutinins requires multiple mutations.
J Virol. 2026;100:e0106526.
PubMed Abstract available

KUMAR S, Lai L, Ellis ML, Patel A, et al
Immunological imprinting shapes the cross-reactive antibody responses to the KP.2 and LP.8.1 vaccine doses.
J Virol. 2026 Aug 26:e0074926. doi: 10.1128/jvi.00749.
PubMed Abstract available

STADLER E, Mordant F, Gartner M, Docken SS, et al
Reconciliation of titer differences between SARS-CoV-2 neutralizing antibody assays.
J Virol. 2026 Aug 27:e0082326. doi: 10.1128/jvi.00823.
PubMed Abstract available

LIU G, Chen J, Wu F, Wei P, et al
Nanobodies targeting SARS-CoV-2 papain-like protease exert dual antiviral and anti-inflammatory effects.
J Virol. 2026 Aug 28:e0059926. doi: 10.1128/jvi.00599.
PubMed Abstract available

XIE E, Schubert M, Reeb J, Seligmann B, et al
Arp2/3 complex-dependent actin remodeling is required for efficient RSV uncoating in A549 cells.
J Virol. 2026;100:e0111726.
PubMed Abstract available

ULLAH R, Chen W, Zhang L, Guo C, et al
Interaction between DEAD-box RNA helicase 10 and influenza PB1 polymerase selectively regulates influenza A virus replication.
J Virol. 2026 Sep 22:e0081526. doi: 10.1128/jvi.00815.
PubMed Abstract available

LEMUS-REYES JI, Fernandez-Quintero ML, Ayala E, Swanson OM, et al
Antigenic and structural analysis of the influenza hemagglutinin lateral patch.
J Virol. 2026 Sep 23:e0126526. doi: 10.1128/jvi.01265.
PubMed Abstract available

PARK H-S, Matsuoka Y, Santos C, Duncan EF, et al
Co-administration of intranasal parainfluenza virus vaccines expressing antigenically distinct SARS-CoV-2 S antigens elicits broad and durable immunity in hamsters.
J Virol. 2026 Sep 24:e0093826. doi: 10.1128/jvi.00938.
PubMed Abstract available

PLoS One

SODERSTROM LINDSTROM H, Norstrom SH, Tang C, Lindberg RH, et al
Occurrence of influenza antivirals and resistance development in influenza A viruses in aquatic environments: A risk assessment.
PLoS One. 2026;21:e0358447.
PubMed Abstract available

OHLSON A, Rehn M, Kuhlmann Berenzon S, Sturegard E, et al
Evaluation of wastewater SARS-CoV-2 surveillance for monitoring COVID-19 trends and early warning in Sweden, 2023-2024.
PLoS One. 2026;21:e0358326.
PubMed Abstract available

VAN KOEVERING K, Hong Y, Kleinberg J
Social tectonics: Rapid organization of online COVID communities.
PLoS One. 2026;21:e0355369.
PubMed Abstract available

VARGA C
Spatiotemporal clustering of highly pathogenic avian influenza (HPAI) H5N1 at the wild waterfowl-poultry interface: Vector-specific spillover risks in the U.S., 2022-2025.
PLoS One. 2026;21:e0345354.
PubMed Abstract available

ZHANG Y, Zhang Y, Zhao C, Xu X, et al
Quantitative assessment of china's policies on the online sale of prescription drugs.
PLoS One. 2026;21:e0358484.
PubMed Abstract available

AICHBERGER MC, Fetz K, Leong S, Kim HS, et al
Discrimination and technology-based disease control.
PLoS One. 2026;21:e0357004.
PubMed Abstract available

FERNANDEZ-PINEDA M, Swift A, Dolbier C, Swanson M, et al
Navigating grief and healthcare: Mixed-methods study on patient experiences of miscarriage during COVID-19.
PLoS One. 2026;21:e0359158.
PubMed Abstract available

BIR C, Widmar NO, Wolf CA, Sheridan T, et al
Societal values versus individual rights with respect to public health related practices during the COVID-19 pandemic in the U.S.
PLoS One. 2026;21:e0358741.
PubMed Abstract available

Proc Natl Acad Sci U S A

MAROUGKA K, Leiva-Rebollo R, Hofma F, van Dijk A, et al
Substitutions affecting the HA-NA-receptor balance preceded the emergence of the pandemic 2009 H1N1 virus.
Proc Natl Acad Sci U S A. 2026;123:e2609870123.
PubMed Abstract available

Vaccine

SCHAFFNER W, Gravenstein S, Kissler S, Cornely OA, et al
Multicomponent vaccination against seasonal influenza and COVID-19: a strategy to address the continued global burden of disease in adults.
Vaccine. 2026;93:129082.
PubMed Abstract available

Virology

ROWE T, Ross TM
Transcriptional decoupling of the epithelial-immune bridge is associated with suboptimal influenza B virus immunogenicity.
Virology. 2026;625:111075.
PubMed Abstract available

Virus Res

WU Q, Wang ZZ, Wang ZM, Wang YH, et al
Development and validation of a broadly cross-reactive polyclonal antibody as capture antibody for pan human beta coronavirus antigen detection.
Virus Res. 2026;372:199786.
PubMed Abstract available

MANEESRIWONGUL W, Deesamer S, Butsing N
Factors influencing Thai parents' COVID-19 vaccine acceptance for their children: Vaccine attitudes, beliefs, and children's past influenza vaccination.
Virus Res. 2026 Sep 20:199805. doi: 10.1016/j.virusres.2026.199805.
PubMed Abstract available

JANG Y, Cha RM, Park MJ, Kim JM, et al
Genetic Diversity of Clade 2.3.4.4b H5Nx High Pathogenicity Avian Influenza Viruses Detected in Korea During the 2025-2026 Winter Season and Pathogenicity of H5N1 and H5N9 Viruses.
Virus Res. 2026 Sep 22:199807. doi: 10.1016/j.virusres.2026.199807.
PubMed Abstract available

Giuseppe Michieli

I am an Italian blogger, active since 2005 with main focus on emerging infectious diseases such as avian influenza, SARS, antibiotics resistance, and many other global Health issues. Other fields of interest are: climate change, global warming, geological and biological sciences. My activity consists mainly in collection and analysis of news, public services updates, confronting sources and making decision about what are the 'signals' of an impending crisis (an outbreak, for example). When a signal is detected, I follow traces during the entire course of an event. I started in 2005 my blog ''A TIME'S MEMORY'', now with more than 40,000 posts and 3 millions of web interactions. Subsequently I added an Italian Language blog, then discontinued because of very low traffic and interest. I contributed for seven years to a public forum (FluTrackers.com) in the midst of the Ebola epidemic in West Africa in 2014, I left the site to continue alone my data tracking job.

Monday, September 21, 2026

Limited added #benefit of seasonal #influenza #vaccination before #H5 vaccination in mice and #ferrets challenged with #H5N1

ABSTRACT

Limited A(H5)-specific vaccine supply is expected early in a potential A(H5N1) pandemic, raising the question of whether licensed seasonal influenza vaccines could enhance protection when administered before A(H5) vaccination. We evaluated this strategy in mouse and ferret models using clade 2.3.4.4b A(H5N1) viruses. Seasonal influenza vaccination induced antibodies to seasonal haemagglutinins but did not induce detectable antibodies against A(H5) and did not consistently enhance A(H5)-directed antibody responses after A(H5) vaccination. In lethal challenge studies, seasonal vaccine priming before A(H5) vaccination was associated with improved outcomes compared with A(H5) vaccination alone in one of three mouse experiments, but this effect was not observed in the other two mouse experiments or in ferrets. These findings suggest that seasonal influenza vaccine priming provides limited added benefit to A(H5) vaccine-mediated protection against A(H5N1) under the conditions tested.

Source:

Link: https://doi.org/10.1080/22221751.2026.2731495

____

Giuseppe Michieli

Saturday, September 19, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, September 19 '26)

Arch Virol

SEO H, Rauf A, Seo SH
Enhanced induction of inflammatory cytokines in human lung cells infected with highly pathogenic recent H5N1/2024 avian influenza virus.
Arch Virol. 2026;171:278.
PubMed Abstract available

BMC Pediatr

MAITITUERSUN Y, Su R, Yang G, Taerken AY, et al
A longitudinal study on differential impacts of the COVID-19 pandemic and normalized prevention and control on overweight and obese adolescents in China.
BMC Pediatr. 2026;26:882.
PubMed Abstract available

O'SHEA TM, McGrath M, Douglas J, Blackwell CK, et al
Child health-related behaviors, social connectedness, and impact of the COVID-19 pandemic on children born preterm in the ECHO Cohort.
BMC Pediatr. 2026 Jul 20. doi: 10.1186/s12887-026-07337.
PubMed Abstract available

Cell

WU Q, Seydlitz LM, Iakimov V, Hsu DJ, et al
Dietary arginine drives codon-dependent MHC class I translation and improves immunity in colon tumorigenesis and respiratory viral infection.
Cell. 2026;189:6012-6023.
PubMed Abstract available

Eur J Epidemiol

KOSTER EAS, Sluiskes MH, Putter H, Rosendaal FR, et al
Dynamics of infection, vaccination and excess mortality during the COVID-19 pandemic among older individuals-a nationwide analysis.
Eur J Epidemiol. 2026;41:869-880.
PubMed Abstract available

LEHNER CT, Anastasova I, Schauberger G, Eberl M, et al
Increasing incidence of type 1 diabetes in children and adolescents from 2012 to 2021 in Germany: trends before and during the COVID-19 pandemic.
Eur J Epidemiol. 2026;41:881-892.
PubMed Abstract available

J Gen Virol

ROSS RA, Walsh SK, Montgomery H, Chen H, et al
Bovine mammary tissues are susceptible to infection by viruses bearing panzootic H5N1 influenza A virus glycoproteins.
J Gen Virol. 2026;107:002338.
PubMed Abstract available

J Infect

HARRIS R, Thirard R, Iftikhar H, Middleditch A, et al
Corrigendum to "Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: A randomised controlled trial" [J Infect 93 (2026) 106784].
J Infect. 2026;93:106853.
PubMed

PLoS Biol

VALENCA-PEREIRA F, Johnson B, DeGregori J, Rincon M, et al
Does acute inflammation triggered by infection promote cancer progression?
PLoS Biol. 2026;24:e3003962.
PubMed Abstract available

PLoS Comput Biol

D'AVANZO M, Myint AP, Cacciapaglia G, Hohenegger S, et al
From sequences to strategies: Early detection of new SARS-CoV-2 variants via genetic distance to reduce hospitalizations.
PLoS Comput Biol. 2026;22:e1014707.
PubMed Abstract available

PLoS One

YANG SL, Liu MT, Huang HH, Lin SW, et al
Epidemiology of human RSV in Taiwan, 2018-2024.
PLoS One. 2026;21:e0357769.
PubMed Abstract available

WOLSKO C, Marino E
Incorporating public values into public health communications: Effects of value affirmations on intentions to vaccinate and trust in the U.S.
PLoS One. 2026;21:e0356783.
PubMed Abstract available

FUENTES K, Jacobson D, Birze A, Cadel L, et al
Building capacity in health systems with and for caregivers: A photovoice protocol.
PLoS One. 2026;21:e0358550.
PubMed Abstract available

LI Q, Tang Y, Shi Y, Wu Y, et al
Census-based adolescent depression risk assessment: A novel method and reflections.
PLoS One. 2026;21:e0357661.
PubMed Abstract available

VENKATESAN S, White L, Koo HN, Dickerson J, et al
Estimating cumulative incidence from partially missing time series of respiratory viral infections.
PLoS One. 2026;21:e0353681.
PubMed Abstract available

AKTAS N, Ersoy A, Oruc A, Ortac H, et al
Attitudes, perceptions, behaviours, and concerns of patients listed for kidney transplantation during the COVID-19 pandemic.
PLoS One. 2026;21:e0358328.
PubMed Abstract available

AL-MAGABLEH M, Muhaisen AHM, Ateir RM, Abu Eraq SA, et al
Herbal or conventional medicine? A cross-sectional study of Jordanian university students' preferences for cold and flu treatment.
PLoS One. 2026;21:e0358179.
PubMed Abstract available

SUERDEM A, Zdravkov S, Ivanov MJ
Beyond deficit and coexistence: Modeling the knowledge-conspiracy-mistrust configuration in public understanding of science.
PLoS One. 2026;21:e0341946.
PubMed Abstract available

GWANZURA TNR, Trepka MJ, Li T, Juhasz L, et al
COVID-19 mortality risk among people with HIV in Florida before and after the introduction of COVID-19 vaccines: A population-based study.
PLoS One. 2026;21:e0358543.
PubMed Abstract available

DE VERAS BMG, Michelin L, Croda J, Berra TZ, et al
Burden of respiratory syncytial virus (RSV) hospitalizations among adults aged 60 years or more in Brazil: A retrospective surveillance database analysis (2013-2024).
PLoS One. 2026;21:e0357303.
PubMed Abstract available

Vaccine

HOEN L, Lartey S, Pathirana RD, Cox RJ, et al
Elucidating the role of pre-existing immunity in mucosal lymphoid architectural dynamics following live attenuated influenza vaccination.
Vaccine. 2026;92:129139.
PubMed Abstract available

GUO J, Dai C, Huang Y, Dai J, et al
Preclinical toxicity and immunogenicity of a quadrivalent recombinant influenza hemagglutinin vaccine (SCVC101) in rhesus monkeys.
Vaccine. 2026;92:129137.
PubMed Abstract available

LAOHARATTANAHIRUN N, Kiertiburanakul S, Boonnak K, Bruminhent J, et al
Immunogenicity and safety of high-dose versus standard-dose quadrivalent inactivated influenza vaccine in patients living with HIV: a randomized controlled trial.
Vaccine. 2026;92:129166.
PubMed Abstract available

OSTROWSKY JT, Gellin BG, Cavaleri M, Bresee JS, et al
Innovation, development, and licensure of improved influenza vaccines: the way forward.
Vaccine. 2026;92:129135.
PubMed Abstract available

ZHOU B, Wang J, Knote C
Seasonal influenza vaccination coverage and population health burden in Europe during the 2019/2020 and 2021/2022 influenza seasons: an ecological panel analysis using principal-component-adjusted multivariable regression.
Vaccine. 2026;92:129163.
PubMed Abstract available

Giuseppe Michieli

Sunday, September 13, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, September 13 '26)

Antimicrob Agents Chemother

PENG Z, Yuan H, Huang J, Lin X, et al
A novel ursodeoxycholic acid derivative exhibits broad-spectrum antiviral activity against influenza A virus and coronaviruses by multiphasic disruption of the viral life cycle.
Antimicrob Agents Chemother. 2026 Sep 9:e0028426. doi: 10.1128/aac.00284.
PubMed Abstract available

BMC Pediatr

BOZZOLA E, Piccotti E, D'Auria E, Trapani S, et al
RESPIRIAMO - Italian hospital surveillance for lower respiratory tract infections: a multicenter retrospective cohort study of respiratory syncytial virus-associated hospitalizations in children under 2 years of age.
BMC Pediatr. 2026;26:853.
PubMed Abstract available

J Infect

ZHU X, Deng Y, Xiao G, Zhang J, et al
Re-emergence of H10N3 Avian Influenza Viruses in China: Evolutionary Dynamics and Emerging Zoonotic Risk.
J Infect. 2026 Sep 7:106848. doi: 10.1016/j.jinf.2026.106848.
PubMed

J Virol Methods

EZEANYAEGBU CN, Toledo NP, Corkum CP, Nelder M, et al
Evaluation of one-step amplicon-based targeted enrichment for SARS-CoV-2 whole-genome sequencing using the Midnight amplicon scheme.
J Virol Methods. 2026;346:115448.
PubMed Abstract available

KAZEMIAN S, Pedroza S, Santana-Pereira ALR, Neasham PJ, et al
An enhanced multisegment RT-PCR method for influenza A virus sequencing: Improved performance and reduced preparation time over traditional methods.
J Virol Methods. 2026;347:115453.
PubMed Abstract available

PLoS Comput Biol

QUILTY BJ, Chapman LAC, Munday JD, Wong KLM, et al
Disentangling the drivers of heterogeneity in SARS-CoV-2 transmission from data on viral load and daily contact rates.
PLoS Comput Biol. 2026;22:e1014715.
PubMed Abstract available

SONG P, de Vlas SJ, Emery T, Coffeng LE, et al
Mapping spatial colleague connectivity patterns from individual-level registry data to inform regional pandemic interventions.
PLoS Comput Biol. 2026;22:e1014721.
PubMed Abstract available

PANT B, Lalovic M, Kiss IZ, Santillana M, et al
The paradox of neglecting changes in behavior: How standard epidemic models misestimate both transmissibility and final epidemic size.
PLoS Comput Biol. 2026;22:e1014746.
PubMed Abstract available

YUAN Z, Zhang X, Lin G, Zou Q, et al
AET5: A transcriptome-guided molecular generation framework with contrastive self-supervised learning.
PLoS Comput Biol. 2026;22:e1014703.
PubMed Abstract available

BENHAMOU W, Howerton E, Park SW, Viboud C, et al
Leveraging perturbations to infer the population dynamics of human rhinovirus and interaction of influenza A virus.
PLoS Comput Biol. 2026;22:e1014784.
PubMed Abstract available

PLoS Med

LENGLART L, Titomanlio L, Alberti I, Almeida L, et al
Association between nirsevimab coverage and pediatric emergency department visits for bronchiolitis in 12 European countries: An interrupted time-series analysis.
PLoS Med. 2026;23:e1005223.
PubMed Abstract available

PLoS One

KWON K, Jang CY, Kim W, Son J, et al
Kinetics of the PASC Index in Long COVID.
PLoS One. 2026;21:e0357670.
PubMed Abstract available

BATTU S, Moore AR, Lebold K, Pacheco-Navarro A, et al
Outcomes of immunocompromised and non-immunocompromised patients in the ICU diverge late in the pandemic.
PLoS One. 2026;21:e0357181.
PubMed Abstract available

JI M, Dong H, Xu Y, Wang Y, et al
Development of a multiplex real-time PCR assay with fluorescence probe-melting-curve analysis for one-tube detection of respiratory pathogens.
PLoS One. 2026;21:e0357377.
PubMed Abstract available

GONG X, Liu L, Lu Y, Zhang G, et al
Sleepless in America: A social sensing study of pandemic-era sleeplessness using nighttime social media data.
PLoS One. 2026;21:e0356547.
PubMed Abstract available

BHATIA A, Elser J, Carrell SJ, Kronmiller B, et al
Correlation assessment of SARS-CoV-2 variants and their subvariants present in clinical and wastewater samples in Oregon, USA (February 7, 2021 - February 26, 2022) using the Freyja bioinformatics approach.
PLoS One. 2026;21:e0357591.
PubMed Abstract available

MOHD YUSOFF H, Yew SQ, Mohd Nawi A, Mohd Tohit N, et al
Prevalence and risk factors of adverse work outcomes among manufacturing workers with Long COVID in Malaysia - A nationwide study.
PLoS One. 2026;21:e0357125.
PubMed Abstract available

VALDES-LOPEZ JF, di Filippo D, Penagos S, Hernandez-Sarmiento LJ, et al
SARS-CoV-2 infection induces functional impairment of vitamin D receptor signaling to drive interleukin 6-dependent hyperinflammation in mononuclear phagocytes.
PLoS One. 2026;21:e0357030.
PubMed Abstract available

AMARSANAA J, Nguyen TXT, Khan MSR, Kadoya Y, et al
The dynamics of loneliness: A longitudinal exploration of transitions in Japan across the COVID-19 period, 2020-2024.
PLoS One. 2026;21:e0358269.
PubMed Abstract available

Proc Natl Acad Sci U S A

LI L, Nguyen L, Qu H, Wu Q, et al
Increased receptor binding and spike glycosylation, remodeled immune escape of surging SARS-CoV-2 subvariant BA.3.2.2/RE.2.2/Cicada.
Proc Natl Acad Sci U S A. 2026;123:e2614163123.
PubMed Abstract available

Vaccine

BUCKLIN R, Gauthreaux N, Faber E, Askelson N, et al
Listening to micropolitan community leaders to support pandemic response efforts.
Vaccine. 2025;60 Suppl 1:127255.
PubMed Abstract available

HOLLIDAY RC, Darkwa A, Brooks GA, Akintobi TH, et al
Developing counter-narratives to address COVID-19 misinformation among 18-24 year olds in community and campus settings.
Vaccine. 2025;60 Suppl 1:127135.
PubMed Abstract available

HEIMAN SL, Geiger N
Overestimation of racial ingroup worry about the COVID-19 vaccine and medical racism.
Vaccine. 2026;91:129046.
PubMed Abstract available

DUTTA S, Ngemera D, Jaillard P, Juneja S, et al
Lessons learnt from one-year cold chain support for COVID-19 vaccination in 5 middle income countries of North Africa.
Vaccine. 2026;91:128994.
PubMed Abstract available

CAMPBELL STATLER M, Bishop-Royse J, Sampson AT, Martin M, et al
Heterogeneity among the vaccine hesitant: A secondary analysis of the national CEAL Common Survey data.
Vaccine. 2026;91:129024.
PubMed Abstract available

KIM SJ, Kim HW, Son SE, Song JH, et al
Wuhan-ancestral multi-antigen SARS-CoV-2 virus-like particles protect against the omicron sublineage JN.1 variant.
Vaccine. 2026;91:129059.
PubMed Abstract available

FAHFOUHI Y, Fievez S, Cohen R, Levy C, et al
A health-economic assessment of the impact of different RSVpreF maternal vaccine strategies to prevent RSV infections among young infants, in France: EPIPACT.
Vaccine. 2026;91:129036.
PubMed Abstract available

BERIKOPOULOU MM, Tatsi EB, Siahanidou T, Michos A, et al
Systematic review of the mutations in the active antigenic site O of the prefusion F protein of the Respiratory Syncytial Virus (RSV) following the implementation of monoclonal antibody prophylaxis.
Vaccine. 2026;91:129069.
PubMed Abstract available

NUNES JPDS, Daher IP, Pires ADS, Yamamoto MM, et al
Synergistic effect of AddaS03 and poly I:C adjuvants on antibody titers and Th1-biased T cell responses following RBD vaccination in BALB/c mice.
Vaccine. 2026;91:129073.
PubMed Abstract available

MONOI A, Endo A, Kriznar M, Suzuki M, et al
Comparing the potential impacts of seasonal immunisation against year-round immunisation to prevent RSV infant hospitalisations in Japan: A modelling study.
Vaccine. 2026;91:129079.
PubMed Abstract available

SCHRARSTZHAUPT IN, Diaz-Quijano FA
Effectiveness of COVID-19 vaccination schedules against severe COVID-19 in children aged 6 months to 4 years in Brazil: A population-based cohort study (2023-2024).
Vaccine. 2026;91:129096.
PubMed Abstract available

ALAMI A, Lewis M, El-Chaar D, Walker M, et al
Maternal vaccination with RSVpreF and risk of hypertensive disorders of pregnancy: a systematic review and meta-analysis.
Vaccine. 2026;91:129070.
PubMed Abstract available

DENG L, Ye X, Chen X, Hu X, et al
Secretory expression of tetrameric neuraminidase enhanced by signal peptide optimization elicits robust immunity against influenza infection in mice.
Vaccine. 2026;92:129118.
PubMed Abstract available

SANBORN J, Robertson MM, Penrose K, Rane M, et al
Gaps between willingness and uptake of influenza and COVID-19 vaccines during the 2025-26 respiratory virus season in a U.S. adult cohort.
Vaccine. 2026;92:129126.
PubMed Abstract available

LU J, Ouyang Z, Huang F, Xie X, et al
Real-world effectiveness of the influenza vaccine among school-aged children in Shenzhen, China, 2024-2025 season: A test-negative design study.
Vaccine. 2026;92:129100.
PubMed Abstract available

THAKKAR V, Aryan Y, Gautam S, Joshi R, et al
Influence of vaccine delivery route on immune imprinting in influenza vaccination.
Vaccine. 2026;92:129109.
PubMed Abstract available

TORAIH EA, Hussein MH, Thomas SJ, Aiash H, et al
Cardiac outcomes following SARS-CoV-2 infection versus BNT162b2 vaccination in adolescents and young adults: a cohort study of 4 million individuals.
Vaccine. 2026;91:129001.
PubMed Abstract available

CABURNAY CA, Fu QJ, Carter T, Butler T, et al
Identification of best outreach strategies and delivery modalities for population subgroups for COVID-19 vaccination.
Vaccine. 2026;60 Suppl 1:128721.
PubMed Abstract available

CANACA G, Vicuna B, Hess JM, Cruz TH, et al
From engagement to ownership: a qualitative study of a community-academic partnership to promote COVID-19 vaccine confidence among Latino/Hispanic communities in New Mexico.
Vaccine. 2026;60 Suppl 1:128583.
PubMed Abstract available

STIEHL E, Negrete M, Flores G, Federmeyer L, et al
Empowering communities during the COVID-19 pandemic: insights from trusted messengers about their work addressing COVID-19 vaccine hesitancy.
Vaccine. 2026;60 Suppl 1:128559.
PubMed Abstract available

NUNO T, Soto S, Sepulveda R, Sierra LA, et al
The Arizona prevention research center vaccine confidence network: A Mobile health unit intervention and survey results of barriers and facilitators to COVID-19 vaccination.
Vaccine. 2025;60 Suppl 1:127970.
PubMed Abstract available

HARA-HUBBARD KK, Beaulieu A, Mendiola A, Gandhi P, et al
Strategies for addressing COVID-19 vaccine equity with intermediaries, prevention research centers, and the vaccine confidence network.
Vaccine. 2025;60 Suppl 1:127847.
PubMed Abstract available

CHUVILEVA YE, Kuiper NM, Ramakrishnan A, Goodman K, et al
Weaving a public health network: Process and results from an evaluation of CDC's Prevention Research Centers Vaccine Confidence Network.
Vaccine. 2025;60 Suppl 1:127636.
PubMed Abstract available

ALMUKHTAR S, McWhirter N, Mendiola A, Samuel S, et al
Exploring lingering COVID-19 vaccine hesitancy in three diverse U.S. states: Alabama, Illinois, and Texas.
Vaccine. 2025;60 Suppl 1:127664.
PubMed Abstract available

BEAULIEU A, LaMonaca K, Higginbottom J, Foster J, et al
Utilizing the Program Impact Pathways framework for improving COVID-19 vaccine confidence and uptake: demonstrations of multi-sector collaboration from two geographies in Connecticut.
Vaccine. 2025;60 Suppl 1:127623.
PubMed Abstract available

JEFFERS A, Kuiper NM, Ramakrishnan A, Swarna H, et al
Building trust in community-academic partnerships: Strategies for enhancing vaccine confidence and demand - Lessons from Prevention Research Centers.
Vaccine. 2025;60 Suppl 1:127624.
PubMed Abstract available

MCGEE RE, Barrett DA, Bednarczyk RA, Grant-Whitlock M, et al
Engaging rural and non-Hispanic Black persons in conversations about the COVID-19 vaccine: a process evaluation of a natural helper intervention.
Vaccine. 2025;60 Suppl 1:127587.
PubMed Abstract available

BORG A, Goulding M, Minkah P, Perrone D, et al
Promotion of COVID-19 vaccination for youth and families in Worcester, Massachusetts: a Diffusion of Innovations approach.
Vaccine. 2025;60 Suppl 1:127586.
PubMed Abstract available

SAVAS LS, Cuccaro P, Zhang K, Hernandez R, et al
Factors influencing COVID-19 vaccine uptake among vulnerable communities in Texas: Perceptions of 2-1-1 helpline callers.
Vaccine. 2025;60 Suppl 1:127554.
PubMed Abstract available

TOTZKAY D, Fraustino JD, Costello LM, Jarrett T, et al
Building on West Virginia's innovative COVID-19 public health communication: associations between vaccination beliefs and vaccination messaging, partisanship, and social vulnerability.
Vaccine. 2025;60 Suppl 1:127555.
PubMed Abstract available

O'CONNOR MH, Nyman AL, Ali S, Rothenberg R, et al
Increasing vaccine uptake in a refugee resettlement community with high social vulnerability.
Vaccine. 2025;60 Suppl 1:127552.
PubMed Abstract available

STIEHL E, Borg A, Cullen JP, Mendiola A, et al
Engaging trusted messengers in public health response: Key strategies to building community trust among CDC'S prevention research center's vaccine confidence network.
Vaccine. 2025;60 Suppl 1:127474.
PubMed Abstract available

HARA-HUBBARD KK, Flores Moreno MG, Sanchez M, Abdi N, et al
The partnership for vaccine confidence: community-academic partnerships to promote COVID-19 vaccines to underserved urban and rural communities using the listen, plan, act, evaluate process.
Vaccine. 2025;60 Suppl 1:127487.
PubMed Abstract available

MALLICK K, Handunge VL, Emmons KM, Blondet L, et al
Engaging a community health ambassador model to promote COVID-19 vaccine in three Massachusetts communities.
Vaccine. 2025;60 Suppl 1:127464.
PubMed Abstract available

Virology

ISHIGAKI H, Otaki K, Kitagawa N, Ishida H, et al
Pathogenicity of SARS-CoV-2 Omicron subvariants JN.1, EG.5.1, and BA.2.86.1 in immunologically naive cynomolgus macaques.
Virology. 2026;624:111036.
PubMed Abstract available

LIU Z, Fan M, Zheng Y, Zeng Y, et al
Transcriptome screening identifies circRNA-INSR as a novel host factor associated with avian influenza virus replication.
Virology. 2026;625:111072.
PubMed Abstract available

MILLER AK, Heremia L, Waller SJ, Blanchard SL, et al
Evaluating sampling strategies for the detection of avian influenza viruses in the environment.
Virology. 2026;625:111069.
PubMed Abstract available

Virus Res

ZHAO Y, Fan H
Clinical impact of baloxavir-induced PA I38T/M substitutions in diverse influenza populations: a systematic review and meta-analysis.
Virus Res. 2026;373:199797.
PubMed Abstract available

Giuseppe Michieli

Saturday, September 5, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Sept. 5 '26)

Antimicrob Agents Chemother

DE ANGELIS M, Gori Savellini G, Piselli E, Anichini G, et al
Redox-sensitive factors as targets of thiol compounds to hinder SARS-CoV-2 replication and inflammatory response.
Antimicrob Agents Chemother. 2026;70:e0051826.
PubMed Abstract available
JEENA N, Khan IA
Targeting SARS-CoV-2 programmed -1 ribosomal frameshifting: structural dynamics and RNA-directed antiviral strategies.
Antimicrob Agents Chemother. 2026;70:e0068726.
PubMed Abstract available
AVILA-PONCE DE LEON U, Esmaeili S, Owens K, Schiffer JT, et al
Plasma concentrations of nirmatrelvir and molnupiravir required for inhibition of SARS-CoV-2 replication differ between rhesus macaques and humans.
Antimicrob Agents Chemother. 2026 Aug 5:e0030726. doi: 10.1128/aac.00307.
PubMed Abstract available

Antiviral Res
PU F, Guo Y, Pan X, Liu X, et al
Dual-targeting engineered binding proteins block SARS-CoV-2 infection and complement activation.
Antiviral Res. 2026;254:106515.
PubMed Abstract available
YURGELONIS I, Rai DK, Lee JT, Li Z, et al
Antiviral activity of nirmatrelvir against contemporary SARS-CoV-2 variants.
Antiviral Res. 2026;254:106517.
PubMed Abstract available

Epidemiol Infect
NAQVI OH, Wendelboe AM, Beasley WH, Tyungu DL, et al
Epidemiological characteristics of paediatric COVID-19 and influenza co-infections in the United States, 2020-2024 - CORRIGENDUM.
Epidemiol Infect. 2026;154:e111.
PubMed

J Infect Dis
ZHAO B, Zhang G, Wu J, Zhang W, et al
Characterization of bronchiolitis and vaccine-induced enhanced respiratory disease in Syrian hamsters caused by respiratory syncytial virus infection.
J Infect Dis. 2026 Mar 4:jiag136. doi: 10.1093.
PubMed Abstract available

J Virol
BHAVSAR D, Civljak A, Bonnettaz B, Arunkumar GA, et al
Broadly reactive antibodies against influenza B virus hemagglutinin neutralize and protect through distinct structural mechanisms.
J Virol. 2026 Sep 4:e0080226. doi: 10.1128/jvi.00802.
PubMed Abstract available
LIU D, Zhang Y, Zhang M, Guo R, et al
A neuraminidase-targeting nanobody as a therapeutic candidate against influenza A and B viruses.
J Virol. 2026 Aug 31:e0087426. doi: 10.1128/jvi.00874.
PubMed Abstract available

JAMA
SENERTH E, Sheikholeslamian SM, Sivakumaran K, Watson MA, et al
Influenza Vaccine Effectiveness and Safety for the 2026-2027 Respiratory Season.
JAMA. 2026 Sep 2. doi: 10.1001/jama.2026.18126.
PubMed Abstract available

Pediatrics
CHAN OW, Cheng YT, Liu YH, Chou IJ, et al
Anakinra in Severe RSV-Associated Autoinflammatory Encephalopathy With Delayed ADEM-Like Changes.
Pediatrics. 2026;158:e2026076364.
PubMed Abstract available
PAYNE AB, Battan-Wraith S, Reese SE, Hathaway CA, et al
Effectiveness of RSV Prevention Strategies in US Infants: 2024-2025.
Pediatrics. 2026 Aug 4:e2026076089. doi: 10.1542/peds.2026-076089.
PubMed Abstract available
MIN J, Tam V, Jacoby SF, McDonald CC, et al
Community Firearm Violence, Youth Depression, and Suicide Risk in Philadelphia: 2017-2024.
Pediatrics. 2026;158:e2025075438.
PubMed Abstract available

PLoS Comput Biol
FREEDMAN AS, Nielsen BF, Saad-Roy CM, Grenfell BT, et al
Economic factors promoting vaccine nationalism in the face of viral evolution.
PLoS Comput Biol. 2026;22:e1014466.
PubMed Abstract available

PLoS Med
ELIAS KM, Mitchell A, Stadler E, Schlub TE, et al
Neutralising antibodies and protection from progression to severe COVID-19: A meta-analysis.
PLoS Med. 2026;23:e1005230.
PubMed Abstract available

PLoS One
ADAMCZYK G, Jablonski A, Nowakowski PT, Ptaszek RT, et al
Theodicy perspective as an effect of the interpenetration of mental and religious issues during the COVID-19 pandemic in Poland.
PLoS One. 2026;21:e0355379.
PubMed Abstract available
JUNGMANN SM, Garbe Huedo SF, Jacobs KAS, Pothorn NK, et al
Mental load in women and mothers: Causes of distress, personality traits, and psychopathology.
PLoS One. 2026;21:e0356255.
PubMed Abstract available
MOUNADI N, Nour H, El Kouali M, Samadi A, et al
Repositioning antiviral phytoconstituents as broad-spectrum inhibitors of influenza A neuraminidase and human metapneumovirus fusion protein.
PLoS One. 2026;21:e0348517.
PubMed Abstract available
HAWKES BA, Hollister J, Porter C, Lyski ZL, et al
Age-specific humoral immune response to SARS-CoV-2: A comparative analysis of antibody levels in children and adults after vaccination with primary series or infection.
PLoS One. 2026;21:e0356178.
PubMed Abstract available
AVSAR FN, Kilicaslan N, Sahutoglu T
Comparative associations of Anakinra and Tocilizumab initiation with in-hospital mortality in severe COVID-19: A single-center sequential cohort study.
PLoS One. 2026;21:e0357671.
PubMed Abstract available
SEEGERT N, Gaulin M, Chaiyakunapruk N, Navarro-Sanchez F, et al
The impact of state- versus county-level mask mandates on economic activity during the COVID-19 pandemic.
PLoS One. 2026;21:e0332243.
PubMed Abstract available
HARDY MJ, Williams CK, Ladman BS, Pitesky ME, et al
Using high frequency GPS data to assess wintering goose proximity to commercial poultry facilities on the Delmarva peninsula for avian influenza risk management and surveillance.
PLoS One. 2026;21:e0355415.
PubMed Abstract available
KOPP J, Spies Rodriguez DC, Kunzi L, Puhan MA, et al
Physical activity in post-COVID-19 condition: A cross-sectional study.
PLoS One. 2026;21:e0357465.
PubMed Abstract available

Proc Natl Acad Sci U S A
KARADAKIC R, Keating NL, Barnett ML
Interpreting vaccine-associated survival differences in immune checkpoint inhibitor therapy.
Proc Natl Acad Sci U S A. 2026;123:e2621501123.
PubMed Abstract available

Vaccine
MOHAMMED H, Andraweera P, Marshall HS
A cohort study to assess the safety and coverage of COVID-19, influenza, and pertussis vaccine in Australian pregnant women.
Vaccine. 2026;91:129081.
PubMed Abstract available
SHEN AK, Tupps C, Bino S, Chipoya M, et al
Investments in seasonal influenza vaccination programs pack a punch for pandemic preparedness.
Vaccine. 2026;92:129098.
PubMed Abstract available
TRAN S, McClymont E, Blitz S, Barrett J, et al
Self-reported reactogenicity after COVID-19 vaccination with and without influenza vaccine coadministration during pregnancy in Canada.
Vaccine. 2026;92:129122.
PubMed Abstract available
MARIA DA, Martins IM, Porto GPM, Villas-Boas IM, et al
Safety, humoral and cellular immune responses to a pre-pandemic adjuvanted influenza A (H5N8) vaccine.
Vaccine. 2026;92:129049.
PubMed Abstract available
ZHENG Y, Qiao B, Gao Z, Zhang X, et al
Development of a subunit vaccine candidate (RBD-HA trimer) provides dual protection against multi-subtype avian influenza viruses and QX-type infectious bronchitis virus.
Vaccine. 2026;92:129121.
PubMed Abstract available
KORNUTA CA, Zhou G, Kane KP, Vliagoftis H, et al
Mucosal adjuvant activity of a PAR-2-activating peptide enhances lymph node immune cell recruitment and promotes immune cell activation in a prime-boost influenza vaccination model.
Vaccine. 2026;92:129110.
PubMed Abstract available

Virology
BROGAARD L, Laybourn HA, Kristensen C, Welner S, et al
Site-specific microRNA responses in lungs of pigs depend on the host-adaptation of H1N1 influenza A virus.
Virology. 2026;624:111053.
PubMed Abstract available
SEKINE W, Kamiki H, Ishida H, Matsugo H, et al
HA1-T138A and HA1-Q226L substitutions in H3N2 canine influenza virus contribute to binding to human-type alpha2,6-linked sialic acid receptors.
Virology. 2026;625:111071.
PubMed Abstract available
OLDENSAND F, Rafati N, Van Hoef V, Lundkvist A, et al
Single-cell transcriptomic landscape of avian influenza H9N2 virus infection in human and chicken cells.
Virology. 2026;625:111070.
PubMed Abstract available

Giuseppe Michieli

Monday, August 31, 2026

#Antibody profiles across #H5N1 and previously circulating viruses are highly dynamic and #age- and imprint- independent

Abstract

The increasing incidence of H5N1 influenza virus transmission from animal species to humans has heightened concerns about an imminent H5N1 pandemic. Prior studies using recombinant hemagglutinin and neuraminidase proteins have reported age-dependent cross-reactivity to H5N1, attributed to immune imprinting from an individual's first influenza virus exposure. However, whether this pattern holds when using whole inactivated virus (WIV), capturing antibodies against diverse viral proteins, and is stable over time remains unknown. We therefore aimed to determine whether H5N1 cross-reactivity of pre-existing antibodies to whole virus follows an age-dependent or imprinting-specific pattern, and whether this pattern is stable over a five-year period. To this end, we measured serum antibody levels in adolescents, adults and seniors by ELISA using whole inactivated H5N1 virus as antigen rather than purified proteins. Detectable, albeit generally low, levels of H5N1-reactive antibodies were present in most individuals, irrespective of age. Comparison of antibody levels against H5N1 with those to five historical influenza virus strains revealed a consistent positive correlation between H5N1-reactive antibodies and responses to the H1N1pdm09 strain A/California/7/2009 (CA), across all age groups. Using unbiased clustering of antibody titers against H5N1, CA, and the H3N2 strain A/Perth/16/2009 (PE), we identified seven distinct age-transcending antibody profiles. These profiles covered individuals with varying titers to all three included viruses but also identified individuals with high anti-CA levels, yet low anti-H5N1 levels and vice versa. Moreover, despite stable antibody levels over a five-year interval in the study population, individual antibody levels and profiles fluctuated considerably over this period. Taken together, our results confirm the presence of H5N1-reactive antibodies in human sera and their association with previously circulating strains. However, they also caution against inferring antibody levels against a new strain based solely on responses to antigenically related strains and highlight the limitations of extrapolating immune status from single timepoint measurements.

Competing Interest Statement

The authors have declared no competing interest.

Source:

Link: https://www.medrxiv.org/content/10.64898/2026.08.26.26361396v1

____

Giuseppe Michieli

Saturday, August 29, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, August 29 '26)

BMC Pediatr

ROHDE G, Haraldstad K, Helseth S, Hagen M, et al
Health-related quality of life in parents of adolescents in 2019, 2021 and 2023.
BMC Pediatr. 2026;26:783.
PubMed Abstract available

ZHU L, Zeng L, Zhang M, Chen X, et al
Comparison of human metapneumovirus and respiratory syncytial virus in children with acute lower respiratory infections in Wenzhou, China from 2021 to 2022: a retrospective study.
BMC Pediatr. 2026;26:774.
PubMed Abstract available

J Immunol

DICK JK, Krishna VD, Hicks D, Sangala JA, et al
ACE2 decoy Fc-fusions and bispecific killer engagers require Fc engagement for in vivo efficacy against SARS-CoV-2.
J Immunol. 2026;215:vkag235.
PubMed Abstract available

J Virol

ALYMOVA IV, Mekonnen B, Wang D, Kamal RP, et al
N-linked glycosylation sites with low occupancy support sustained circulation of the A(H3N2) influenza A virus in the human population.
J Virol. 2026 Aug 28:e0066226. doi: 10.1128/jvi.00662.
PubMed Abstract available

BARRE RS, Nath H, Nogales A, Abdelwhab EM, et al
NS-segment-based reporter influenza A viruses: engineering strategy, applications, and limitations.
J Virol. 2026 Aug 26:e0109926. doi: 10.1128/jvi.01099.
PubMed Abstract available

PLoS Comput Biol

KENNEDY J, Ferguson W, Jones O, Riley S, et al
Evaluation of short-term multi-target respiratory forecasts over winter 2024-25 in England using sub-ensemble contribution analyses.
PLoS Comput Biol. 2026;22:e1014644.
PubMed Abstract available

OSTHUS D, Murph AC, Goldberg EE, Beesley LJ, et al
Leveraging synthetic and genetic data to improve epidemic forecasting.
PLoS Comput Biol. 2026;22:e1014630.
PubMed Abstract available

PLoS One

HO QM, Duong BT, Nguyen LNT, Susilawati TN, et al
ICU admission and mortality in adult patients with influenza A(H1N1)pdm09-related pneumonia in Vietnam since the 2009 H1N1 pandemic: A 10-year cohort study.
PLoS One. 2026;21:e0348450.
PubMed Abstract available

NASH RK, Bhatia S, Wardle J, Cori A, et al
Forecasting COVID-19 cases in US states using reconstructed incidence data.
PLoS One. 2026;21:e0353983.
PubMed Abstract available

ARTEMCHUK O, Chakhunashvili G, Finci I, Rojas M, et al
Factors associated with influenza vaccine uptake among healthcare workers in Georgia, 2021-2024.
PLoS One. 2026;21:e0356495.
PubMed Abstract available

MENDOZA-VELAZQUEZ A, Lara-Arevalo J, Mendoza-Martinez L, Drewnowski A, et al
Rising food prices and widening nutrition gaps in Mexico: The cost of nutrient-dense and ultra-processed foods before, during, and after COVID-19.
PLoS One. 2026;21:e0355198.
PubMed Abstract available

OVERBOSCH FW, Waltz CNM, Cesuroglu T, Blokland B, et al
Exploring integrated advice and avian influenza knowledge gaps by using a Highly Pathogenic Avian Influenza outbreak simulation.
PLoS One. 2026;21:e0354920.
PubMed Abstract available

SHARMA S, Elhassan H, Anderson KK, Heisel MJ, et al
Changes in mental health outcomes of middle-aged and older adults during the COVID-19 pandemic: A scoping review.
PLoS One. 2026;21:e0342140.
PubMed Abstract available

EKHOLUENETALE M
Decomposing socioeconomic inequalities in COVID-19 vaccination uptake among Nigerian women of reproductive age: A further analysis of population-based data.
PLoS One. 2026;21:e0357171.
PubMed Abstract available

PUEBLA G, Ferrer-Urbina R, Perez-Zapata D, Alarcon-Castillo K, et al
Cognitive load and individual differences as drivers of health-related misinformation: A signal detection approach.
PLoS One. 2026;21:e0356642.
PubMed Abstract available

Proc Natl Acad Sci U S A

RIUMINA ED, Alekseeva EI, Klink GV, Feigin S, et al
HLA class I escape drives the evolution of SARS-CoV-2 in human populations.
Proc Natl Acad Sci U S A. 2026;123:e2619192123.
PubMed Abstract available

LIU Q, Chen P, He C, Qiu Z, et al
SESN1 is a negative regulator of MAVS and dynamically expressed during RNA viral infection.
Proc Natl Acad Sci U S A. 2026;123:e2621443123.
PubMed Abstract available

MONTGOMERIE I, McKenzie RE, Palmer OR, Mason NC, et al
Engineering antigenic breadth against SARS-CoV-2 by pairing divergent RBDs within a single mRNA immunogen.
Proc Natl Acad Sci U S A. 2026;123:e2602574123.
PubMed Abstract available

Vaccine

KOONIN LM, Velez SD, Bresee JS
Expanding adult immunization in low- and middle-income countries through pharmacist-provided vaccination.
Vaccine. 2026;90:129004.
PubMed Abstract available

KAZENZA B, Masokolo B, Mbunga B, Egbende L, et al
Why COVID-19 vaccination struggled in the Democratic Republic of Congo: a qualitative study exploring organizational and sociocultural barriers, 2025.
Vaccine. 2026;90:129033.
PubMed Abstract available

HUIBERTS AJ, Eggink D, de Gier B, Karens T, et al
Effectiveness of Omicron JN.1 vaccination against infection with JN.1-derived SARS-CoV-2 subvariants in a prospective cohort study in the Netherlands.
Vaccine. 2026;90:129030.
PubMed Abstract available

HUTTON DW, Prosser LA, Ortega-Sanchez IR, Leidner AJ, et al
Evaluating the cost-effectiveness of respiratory syncytial virus vaccination among risk-stratified older adults.
Vaccine. 2026;90:129023.
PubMed Abstract available

PORTILHO AI, Andreata-Santos R, Duarte-Barbosa M, Chaves APC, et al
Functional neutralizing and bactericidal antibody responses induced by dual-target immunization with SARS-CoV-2 RBD and Neisseria meningitidis antigens in mice.
Vaccine. 2026;90:129011.
PubMed Abstract available

AHI T, Andersen KM, Mateus JS, Yu T, et al
2024-2025 BNT162b2 KP.2 COVID-19 full season vaccine effectiveness from vaccine registries linked to administrative claims in two states: A cohort study in non-immunocompromised adults.
Vaccine. 2026;90:129009.
PubMed Abstract available

LIU X, Cloughesy JN, Yu T, Ferranna M, et al
Uptake of the RSVpreF vaccine during pregnancy: associations with socioeconomic status, prenatal care utilization, and maternal risk factors.
Vaccine. 2026;90:129003.
PubMed Abstract available

KAZI F, Shapland CY, Spiga F, Villanueva G, et al
Implications for future pandemics from a living systematic review and critical evaluation of observational studies of the effectiveness of COVID-19 vaccination against the Omicron variant.
Vaccine. 2026;90:128993.
PubMed Abstract available

HUIBERTS AJ, Smits MMJ, Hoeve CE, de Melker HE, et al
Association between post-vaccination adverse events and subsequent COVID-19 booster uptake in the Netherlands.
Vaccine. 2026;90:129043.
PubMed Abstract available

GENSOROWSKY D, Surmann B, Meyer AC, Poshtiban A, et al
Corrigendum to "Outpatient care intensity and influenza vaccination: evidence from Germany" [Vaccine 70 (2026) 128038].
Vaccine. 2026;90:129062.
PubMed

BOTT L, Liu J, Challenger A, Powell E, et al
Myth-busting influenza and fear of adverse reactions in healthcare workers: two experimental studies on vaccination intentions.
Vaccine. 2026;91:129086.
PubMed Abstract available

Giuseppe Michieli

Saturday, August 22, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, August 22 '26)

BMC Pediatr

XIA Z, Zhang H, Xu S, Lin X, et al
Changes in pediatric pneumonia incidence and pathogen spectrum before, during, and after the COVID-19 pandemic: an eight-year inpatient data analysis from a tertiary hospital in Fujian, China.
BMC Pediatr. 2026;26:766.
PubMed Abstract available

Cell
LI L, Yan XL, Wang HY, Zhou HY, et al
Viral protease-initiated lytic cell death as a universal antiviral mRNA therapy.
Cell. 2026;189:5396-5410.
PubMed Abstract available

J Gen Virol
SHIM K, Choi JH, Hwang EH, Kim G, et al
Dose-dependent effects of recombinant spike protein-based vaccination on SARS-CoV-2 evolutionary dynamics and the emergence of variants in hamster models.
J Gen Virol. 2026;107:002314.
PubMed Abstract available
GRANSTAD S, Tonnessen R, Ytrehus B, Descamps S, et al
Multiple introductions of highly pathogenic avian influenza viruses into the High Arctic: Svalbard and Jan Mayen, 2022-2025.
J Gen Virol. 2026;107:002305.
PubMed Abstract available

J Virol
XU J, Chan H-w, Yang R, Wu X-R, et al
Nicotine and cotinine enhance SARS-CoV-2 entry through distinct but complementary mechanisms in human respiratory epithelial cells.
J Virol. 2026 Jul 31:e0097126. doi: 10.1128/jvi.00971.
PubMed Abstract available
HE L, Su Y-WN, Zhang F, Moustafa IM, et al
Recovery of proofreading-impaired SARS-CoV-2 reveals a mutator phenotype and an ExoN activity threshold for viability.
J Virol. 2026 Jul 29:e0080926. doi: 10.1128/jvi.00809.
PubMed Abstract available
BEETON K, Case JB
Respiratory mucosal vaccines for emerging viruses: promise and challenges.
J Virol. 2026 Jul 23:e0174825. doi: 10.1128/jvi.01748.
PubMed Abstract available
ZHOU R, Yue M, Shen Q, Liu N, et al
Glucagon-like peptide-1 receptor agonist prevents pulmonary fibrosis following acute COVID-19 infection associated with type 2 diabetes.
J Virol. 2026 Jul 9:e0040126. doi: 10.1128/jvi.00401.
PubMed Abstract available
LAMICHHANE P, Yang L, Santos C, Park H-S, et al
Live human metapneumovirus vaccine candidates attenuated by temperature sensitivity mutations from human respiratory syncytial virus.
J Virol. 2026 Jul 6:e0069226. doi: 10.1128/jvi.00692.
PubMed Abstract available

Pediatrics
HUANG YN, Chang CJ, Dai YL, Kung YH, et al
Early Antiviral Therapy in Pediatric Outpatients and Risk of Influenza-Related Hospitalization.
Pediatrics. 2026 Aug 17:e2025075020. doi: 10.1542/peds.2025-075020.
PubMed Abstract available
ANTOON JW, Edwards KM
Why Not Antivirals? Reconsidering Influenza Treatment in Children.
Pediatrics. 2026 Aug 17:e2026076953. doi: 10.1542/peds.2026-076953.
PubMed

PLoS Comput Biol
KRAMER SC, Pirikahu S, Kussmaul C, Opatowski L, et al
The limitations of non-mechanistic methods for characterizing pathogen-pathogen interactions: A simulation study.
PLoS Comput Biol. 2026;22:e1013859.
PubMed Abstract available
DIMITRIOU PA, D'Alessandro M, Chang BL, Silvestros V, et al
Non-Markovian dynamics and effective reproduction number in COVID-19: Evidence from Cyprus contact tracing data.
PLoS Comput Biol. 2026;22:e1014578.
PubMed Abstract available

PLoS Med
KAMTCHUM-TATUENE J, Farrell J, Nolan J, Lessels S, et al
Time trends in stroke incidence and modifiable risk factor prevalence in England (2018-2024): A record linkage population-based study.
PLoS Med. 2026;23:e1004999.
PubMed Abstract available

PLoS One
DI CHIARA C, Piche-Renaud PP, Rigamonti V, Cantarutti A, et al
Pediatricians' attitudes and knowledge of RSV immunization products: A multi-country cross-sectional survey.
PLoS One. 2026;21:e0356233.
PubMed Abstract available
APONTE-HAO S, Luu H, Martins KJB, Randall JR, et al
Factors associated with severe COVID-19 outcomes among adults with at least a primary vaccination schedule: A retrospective cohort study from Alberta, Canada.
PLoS One. 2026;21:e0354822.
PubMed Abstract available
SHANKER N, Reckling S, Snyder NL, Enright D, et al
Addressing gaps in surveillance: Use of emergency department accessibility and social vulnerability to identify potential wastewater surveillance sites in North Carolina.
PLoS One. 2026;21:e0346668.
PubMed Abstract available
KOSINSKA-SELBI B, Kowalczyk J, Pierscinska J, Weleszczuk J, et al
Comprehensive and innovative post-market surveillance system for atypical respiratory pathogens detecting qPCR panel.
PLoS One. 2026;21:e0349967.
PubMed Abstract available
D'SOUZA-RUSHTON GC, Seshu U, Blumberger L, Mazhar L, et al
The CDC's management and COVID-19 vaccine recommendations during the COVID-19 pandemic: A healthcare worker's perspective.
PLoS One. 2026;21:e0354686.
PubMed Abstract available
MOSSOP B, Choudhury S
Regime-aware causal Bayesian forecasting for non-stationary time series.
PLoS One. 2026;21:e0356474.
PubMed Abstract available
HUNG LF, Guo PX, Hou CY, Kuo YH, et al
Changes in multidrug-resistant Enterobacteriaceae features among patients in the emergency room during the COVID-19 Omicron variant pandemic.
PLoS One. 2026;21:e0355725.
PubMed Abstract available
Correction: The interaction of RNA G-quadruplexes from the influenza A virus vRNA with TMPyP4 and BRACO-19 ligands.
PLoS One. 2026;21:e0356274.
PubMed Abstract available

Vaccine
TANI N, Sato T, Goto T, Harada Y, et al
Longitudinal changes in the antibody responses and adverse reactions across successive SARS-CoV-2 mRNA vaccinations from the primary series to the JN.1-adapted booster in hospital employees: A 4-year prospective cohort study.
Vaccine. 2026;89:128887.
PubMed Abstract available
EZEJA L, Ezeala OM, Westrick SC, Qian J, et al
Adverse events and vaccine administration errors following RSV vaccination: Findings from the United States VAERS database, 2023-2025.
Vaccine. 2026;89:128896.
PubMed Abstract available
LIU STH, Gonzalez-Dominguez I, Martinez-Perez A, Bozkus CC, et al
Phase 1 trial of intranasal NDV-HXP-S in previously vaccinated adults.
Vaccine. 2026;89:128870.
PubMed Abstract available
KAUTZ A, Yang DH, Chickery S, Irving SA, et al
Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.
Vaccine. 2026;89:128891.
PubMed Abstract available
BROWN J, Brennan H, Levine CB, Gwynn L, et al
A historical overview of the anti-vaccine movement and its public health implications.
Vaccine. 2026;89:128903.
PubMed Abstract available
DEPICKERE S, Pannus P, Houben S, Charles A, et al
Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.
Vaccine. 2026;89:128897.
PubMed Abstract available
KANDULU CC, Fleming A, O'Mahony A, McHugh S, et al
Barriers and facilitators to COVID-19 vaccination programme implementation in Ireland: a qualitative study of implementation stakeholders using CFIR.
Vaccine. 2026;89:128909.
PubMed Abstract available
WILLIAMS J, Degeling C, Donovan L, Wiley K, et al
Australians' attitudes to mRNA vaccination in humans and animals: A cross-sectional survey.
Vaccine. 2026;89:128907.
PubMed Abstract available
SANDERS JG, Kroese F, Mehra S, Stok M, et al
Switching the default: a formative evaluation of pre-booked appointments on COVID-19 vaccination uptake and effects on intended uptake.
Vaccine. 2026;89:128967.
PubMed Abstract available
MAZIBUKO L, Hoor D, Nxumalo V, Nxumalo S, et al
The association of individual, interpersonal and social support factors with willingness to vaccinate against COVID-19 in rural South Africa.
Vaccine. 2026;89:128998.
PubMed Abstract available
AUGUSTO LV, de Araujo LP, Silva EN, Gutierres JM, et al
Intersection of vaccination, health literacy, education, and communication in South America: A scientometric mapping.
Vaccine. 2026;89:128986.
PubMed Abstract available
SUZUKI Y, Arita T, Shirakura M, Kishida N, et al
A novel candidate vaccine virus derived from Japan's first mammalian case of clade 2.3.4.4b A/H5N1 highly pathogenic avian influenza virus.
Vaccine. 2026;91:129048.
PubMed Abstract available
DHANDA S, Morris DE, Morton K, Hazell L, et al
Enhanced passive safety surveillance (EPSS) of a seasonal intranasal influenza vaccine (Fluenz(R) Tetra) in children in England: methodology, results and lessons learned from eight influenza seasons (2015/2016 to 2022/2023).
Vaccine. 2026;91:129007.
PubMed Abstract available
HERMANN E, Krammer F
The return of H1N1: Reemergence of the influenza virus A subtype H1N1 in 1977.
Vaccine. 2026;91:128963.
PubMed Abstract available

Giuseppe Michieli

ETIDIOH - NEW

Saturday, September 26, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, September 26 '26)

Monday, September 21, 2026

Limited added #benefit of seasonal #influenza #vaccination before #H5 vaccination in mice and #ferrets challenged with #H5N1

Saturday, September 19, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, September 19 '26)

Sunday, September 13, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, September 13 '26)

Saturday, September 5, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Sept. 5 '26)

Monday, August 31, 2026

#Antibody profiles across #H5N1 and previously circulating viruses are highly dynamic and #age- and imprint- independent

Saturday, August 29, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, August 29 '26)

Saturday, August 22, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, August 22 '26)

My New Space

Most Popular Posts